5.20
+0.77825(+17.60%)
Currency In USD
| Previous Close | 4.42 |
| Open | 4.68 |
| Day High | 5.55 |
| Day Low | 4.64 |
| 52-Week High | 702 |
| 52-Week Low | 2.94 |
| Volume | 165,731 |
| Average Volume | 48,968 |
| Market Cap | 3.03M |
| PE | -0.01 |
| EPS | -612.99 |
| Moving Average 50 Days | 4.63 |
| Moving Average 200 Days | 62.15 |
| Change | 0.78 |
If you invested $1000 in Psyence Biomedical Ltd. Common Shares (PBM) since IPO date, it would be worth $1.4 as of May 16, 2025 at a share price of $5.2. Whereas If you bought $1000 worth of Psyence Biomedical Ltd. Common Shares (PBM) shares 1 year ago, it would be worth $1.4 as of May 16, 2025 at a share price of $5.2.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Psyence BioMed Announces Effective Date for 1-for-7.97 Reverse Stock Split
Newsfile
May 01, 2025 11:30 AM GMT
New York, New York--(Newsfile Corp. - May 1, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced the effective date of its 1-for-7.97 share consolidation (reverse stock split) of the Company's issued and
Psyence BioMed Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Newsfile
Apr 17, 2025 11:17 PM GMT
New York, New York--(Newsfile Corp. - April 17, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") announced today that it received a notification letter dated April 16, 2025, from the Listings Qualifications Department
Psyence BioMed Announces USD$500,000 Follow-On Investment in PsyLabs and Global Ibogaine Supply Agreement
Newsfile
Apr 15, 2025 12:30 PM GMT
New York, New York--(Newsfile Corp. - April 15, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced a strategic follow-on investment of USD $500,000 into PsyLabs, a privately-held company specializing in